Medicalgorithmics stock: Management proposes PLN 33.00 share issue for Medicalgorithmics stock

Published on 10/23/2026 at 06:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

An Asian-listed investor has shown interest in up to 1,000,000 shares, while talks stay preliminary. The November 18 vote concerns Medicalgorithmics stock.

Capital plans and key dates

Medicalgorithmics proposed two share issues on October 21, 2026, including Series S at PLN 33.00 or more.
Estimated third-quarter revenue reached PLN 10.9 million, up 52.00 percent year over year.
The Extraordinary General Meeting is scheduled for November 18, 2026, with a rights record date of November 30, 2026.

Medicalgorithmics, PLMDCLG00015, Illustration mit AI erstellt.

Medicalgorithmics (ISIN PLMDCLG00015) proposed a share issue at a minimum price of PLN 33.00 on October 21, 2026, while discussing a potential investment with an Asian-listed company, Bankier.pl reported on October 22, 2026. The proposal links financing plans with a possible strategic investor, but the company described the discussions as preliminary.

Three dates show the financing path

On October 13, 2026, Medicalgorithmics estimated third-quarter sales revenue at PLN 10.9 million, up 52.00 percent from PLN 7.2 million a year earlier, while estimated EBITDA reached PLN 1.6 million compared with a PLN 2.1 million loss in the prior-year quarter, according to Bankier.pl. On October 21, 2026, the board proposed up to 1,045,339 Series R shares at PLN 20.00 each and up to 1,000,000 Series S shares at a price of at least PLN 33.00, as reported by Bankier.pl. On October 22, 2026, the company announced the planned Extraordinary General Meeting, making the vote the next formal step.

What does the proposed issue mean?

The financing could provide at least PLN 33.0 million from Series S and about PLN 20.9 million from Series R if both offerings are fully subscribed. The proceeds are intended for operations, product development, international expansion and working capital, while the Series S offer would remove existing shareholders' pre-emptive rights. That structure gives the financing plan a clear capital-growth purpose but leaves the strategic investment dependent on further negotiations.

Dates set the next decisions

The Extraordinary General Meeting is scheduled for November 18, 2026, and the proposed record date for Series R pre-emptive rights is November 30, 2026, according to Parkiet. Investors will therefore be assessing both the proposed capital increase and the terms of any eventual strategic subscription.

Medicalgorithmics price context

On the Warsaw Stock Exchange, Medicalgorithmics was last at PLN 23.45 on October 22, 2026 at 4:59 p.m. CEST. Its market capitalization was PLN 245.1 million, and its 52-week range was PLN 22.50 to PLN 38.65 on that date. The further course of trading is shown by the continuously updated real-time quote of Medicalgorithmics stock.